pDONR223-ACVRL1 Citations (2)
Originally described in: COT drives resistance to RAF inhibition through MAP kinase pathway reactivation.Johannessen CM, Boehm JS, Kim SY, Thomas SR, Wardwell L, Johnson LA, Emery CM, Stransky N, Cogdill AP, Barretina J, Caponigro G, Hieronymus H, Murray RR, Salehi-Ashtiani K, Hill DE, Vidal M, Zhao JJ, Yang X, Alkan O, Kim S, Harris JL, Wilson CJ, Myer VE, Finan PM, Root DE, Roberts TM, Golub T, Flaherty KT, Dummer R, Weber BL, Sellers WR, Schlegel R, Wargo JA, Hahn WC, Garraway LA Nature. 2010 Dec 16;468(7326):968-72. doi: 10.1038/nature09627 PubMed Journal
Articles Citing pDONR223-ACVRL1
Articles |
---|
Activation of BMP Signaling by FKBP12 Ligands Synergizes with Inhibition of CXCR4 to Accelerate Wound Healing. Peiffer BJ, Qi L, Ahmadi AR, Wang Y, Guo Z, Peng H, Sun Z, Liu JO. Cell Chem Biol. 2019 May 16;26(5):652-661.e4. doi: 10.1016/j.chembiol.2019.01.011. Epub 2019 Feb 28. PubMed |
Transcriptomic analysis identifies novel targets for individual bone morphogenetic protein type 1 receptors in endothelial cells. Choi W, Lee HW, Pak B, Han O, Kim M, Jin SW. FASEB J. 2021 Mar;35(3):e21386. doi: 10.1096/fj.202002071R. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.